parkinson disease
Showing NaN - NaN of 58
Parkinson Disease Trial in Worldwide (THN102 Dosage A, THN102 Dosage B, THN102 Dosage C)
Completed
- Parkinson Disease
- THN102 Dosage A
- +2 more
-
Kansas City, Kansas
- +33 more
Nov 27, 2020
Parkinson Disease Trial in Worldwide (ExAblate Pallidotomy, Sham ExAblate Pallidotomy)
Active, not recruiting
- Parkinson Disease
- ExAblate Pallidotomy
- Sham ExAblate Pallidotomy
-
Stanford, California
- +19 more
Nov 5, 2020
Parkinson Disease, Movement Disorders, Neuro-Degenerative Disease Trial in Boston (Golf Instruction, Tai Chi Class)
Completed
- Parkinson Disease
- +2 more
- Golf Instruction
- Tai Chi Class
-
Boston, MassachusettsMassachusetts General Hospital
Sep 2, 2020
Parkinson Disease Trial in United States (Cohort 1:Nilotinib Oral Capsules (150mg or 300mg), Cohort 2: Nilotinib Oral Capsules
Completed
- Parkinson Disease
- Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)
- +2 more
-
Birmingham, Alabama
- +23 more
Jul 21, 2020
Parkinson Disease Trial in Boston (e-Tapper TT-R1)
Completed
- Parkinson Disease
- e-Tapper TT-R1
-
Boston, MassachusettsBoston University School of Medicine
Apr 1, 2020
Parkinson Disease Trial in Boston (Rapid Cadence Cycling on a Solo-Rider Spin Bicycle)
Completed
- Parkinson Disease
- Rapid Cadence Cycling on a Solo-Rider Spin Bicycle
-
Boston, MassachusettsMassachusetts General Hospital
Feb 24, 2020
Parkinson Disease Trial in Canada, United States (Isradipine, Placebo (for Isradipine))
Completed
- Parkinson Disease
- Isradipine
- Placebo (for Isradipine)
-
Birmingham, Alabama
- +53 more
Jan 7, 2020
Social Self-Management of Parkinson's Disease
Completed
- Parkinson Disease
-
Boston, Massachusetts
- +1 more
May 2, 2019
eOnOff - D1 Extension
Completed
- Parkinson Disease
- MC10 BioStampRC
- +2 more
-
Boston, MassachusettsEvans Biomedical Research Center
Jan 22, 2019
Parkinson Disease Trial in Boston, Orem, Amsterdam (Spectramax light therapy device, Control light device)
Completed
- Parkinson Disease
- Spectramax light therapy device
- Control light device
-
Boston, Massachusetts
- +2 more
Oct 19, 2018
SAVE (Synuclein Assay Validation Effort)
Completed
- Parkinson Disease
- Procedure/Surgery: Biofluid samplings
-
Chicago, Illinois
- +4 more
Aug 17, 2018
Parkinson Disease Trial in Boston (Balance & Strengthening Exercises)
Completed
- Parkinson Disease
- Balance & Strengthening Exercises
-
Boston, MassachusettsCenter for Neurorehabilitation, College of Health & Rehabilitati
Jul 18, 2017
Parkinson Disease Trial in Boston (Mobile Health Technology, Stretching & Strengthening Exercises, Walking with Pedometer)
Completed
- Parkinson Disease
- Mobile Health Technology
- +2 more
-
Boston, MassachusettsCenter for Neurorehabilitation, College of Health & Rehabilitati
Jul 18, 2017
Parkinson Disease, Parkinson's Disease Trial in Worldwide (Ropinirole XL (formerly CR))
Completed
- Parkinson Disease
- Parkinson's Disease
- Ropinirole XL (formerly CR)
-
Birmingham, Alabama
- +74 more
Mar 21, 2017
Parkinson Disease, Amyotrophic Lateral Sclerosis Trial in Boston (Incobotulinum Toxin A, )
Withdrawn
- Parkinson Disease
- Amyotrophic Lateral Sclerosis
- Incobotulinum Toxin A
- placebo
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 3, 2017
Parkinson Disease Trial in United States (Virtual Visits)
Completed
- Parkinson Disease
- Virtual Visits
-
San Francisco, California
- +19 more
Dec 1, 2016
Parkinson Disease Trial in Boston (Tai Chi)
Completed
- Parkinson Disease
- Tai Chi
-
Boston, MassachusettsBrigham and Women's Hospital
Aug 18, 2016
Parkinson Disease Trial in Germany, Spain, United States (Spheramine (BAY86-5280), Placebo)
Terminated
- Parkinson Disease
- Spheramine (BAY86-5280)
- Placebo
-
Birmingham, Alabama
- +14 more
Sep 23, 2015
Parkinson Disease Trial in United States (Placebo, inosine)
Parkinson Disease Trial in Canada, United States (Isradipine CR 5mg, Isradipine CR 10mg, Isradipine CR 20mg)
Completed
- Parkinson Disease
- Isradipine CR 5mg
- +3 more
-
Sunnyvale, California
- +19 more
Apr 16, 2013